All
Ziftomenib Submits New Drug Application to FDA for R/R NPM1-Mutant AML
The FDA previously granted breakthrough therapy designation to ziftomenib for relapsed/refractory NPM1-mutant AML.
Phase 3 Trial Leads to FDA Approval of Cabometyx in Neuroendocrine Tumors
Based on the phase 3 CABINET trial, the FDA approved Cabometyx for some patients with previously treated neuroendocrine tumors.
NeuroSAFE May Increase Erectile Function After Prostate Cancer Surgery
Use of NeuroSAFE during prostatectomy nearly doubled the number of patients who had no or mild erectile dysfunction approximately a year later.
First Patient Dosed With KSQ-004EX In Solid Tumor Clinical Trial
KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic and cervical cancer.
Imdelltra May Improve Survival in Small Cell Lung Cancer
Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.
A Kidney Cancer Advocate Shares Advice for Newly Diagnosed Patients
Some cancer statistics may reflect 'backwards-looking data', making it important to stay up to date on reliable information and happenings in the space.
Knowing the Signs to Detect and Treat Testicular Cancer Early
Testicular cancer is rare but highly curable, especially with early detection; treatment varies by stage, and follow-up care supports long-term health.
Spring Forward: How I Stay Grounded and Hopeful with Lynch Syndrome
Living with Lynch isn't easy, but it's not all doom and gloom. It's a call to live deliberately.
What Role May ctDNA Have in Melanoma Management?
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
An Expert Breaks Down Lymphedema Following Cancer Care
Dr. Sheri Yolanda Prentiss discusses the importance of seeking early intervention to detect lymphedema following cancer care.
Melanoma Taught Me Faith, Gratitude and That Nothing Is Permanent
I was diagnosed with stage 3 melanoma at 31, faced recurrence and now share my journey to raise awareness, stay hopeful and trust in God’s plan.
FDA Approves Avastin Biosimilar Jobevne Across Several Cancer Types
The FDA has approved Jobevne, a biosimilar to Avastin, for IV use in a number of cancer types.
Managing Cancer Demands With Flexibility and a Strategic Mindset
It isn’t easy having cancer. But like gardening in a harsh climate, survival and growth come from strategies, adaptation, and patience.
FDA Grants Full Approval to Vitrakvi For NTRK-Positive Solid Tumors
Vitrakvi, first granted accelerated approval in 2018, has received full approval from the FDA.
Kaifan Zhao, AGACNP-BC, PMHNP-BC, Wins CURE’s 2025 Extraordinary Healer® Award
The 2025 Extraordinary Healer® Award was presented during the 50th Annual Oncology Nursing Society Congress, recognizing oncology nursing professionals' dedication and impact.
First Patient Dosed in Trial of CT-95 in Mesothelin-Expressing Tumors
CT-95 is being developed for cancers including pancreatic, ovarian and mesothelioma and other solid tumors.
Early Detection and Screening is Key for Esophageal Cancer
Because the five-year relative survival rate for people with esophageal cancer is approximately 22%, this makes early detection of the essence.
Breaking Down Treatment Options for Patients With Head and Neck Cancer
Dr. Lillian L. Siu discussed potential risk factors and treatment strategies associated for patients with head and neck cancer.
Going Off Medication for Lymphoma: Could It Be True?
After living with lymphoma for 15 and a half years, my doctor has suggested reducing the dose of my medication and possibly taking me off of it.
PROSTOX May Predict Urinary Side Effects Post Prostate Cancer Radiation
A test to identify higher risk of developing urinary side effects after radiation in patients with prostate cancer was confirmed by data from a new study.
Early Intervention and Screening Prevents Lymphedema After Cancer
Dr. Sheri Yolanda Prentiss discusses lymphedema as a result of cancer treatment and shares resources that exist for patients coping with this condition.
FDA Grants Positive Review for AML Drug Trial, First Dosing in 2025
The FDA granted a positive review for an acute myeloid leukemia drug trial, with initial dosing expected in 2025.
Cardiometabolic Considerations for Childhood Cancer Survivors Explained
The American Heart Association has released a statement detailing cardiometabolic considerations for survivors of childhood cancer.
Combining Radiation and Breast Reconstruction Strategies in Breast Cancer
Radiation therapy plays an important role in reducing the risk of cancer recurrence for patients with breast cancer undergoing breast reconstruction.
FDA Approves Opdivo Plus Yervoy For Some With Colorectal Cancer
The FDA has approved Opdivo with Yervoy for patients 12 years old and older with MSI-H or dMMR colorectal cancer.
Sometimes Cancer is a (Welcome) Distraction
In an upside-down, topsy-turvy world, cancer can be a distraction for us.
SLS009 May Improve Survival in R/R AML
SLS009 is associated with an improvement in survival among patients with relapsed/refractory acute myeloid leukemia.
A Patient Shares Insights on Kidney Cancer Awareness and Advocacy
Following a social media takeover with CURE, Sid Sadler sat down to talk about the topic of Kidney Cancer Awareness Month and patient advocacy.
Bavencio Has Long-Term Benefit Regardless of Diabetes Status in Bladder Cancer
Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of patients’ diabetes status.
Raising Awareness for Kidney Cancer and the Challenges Patients Face
It is important to recognize Kidney Cancer Awareness Month as a time to get involved, as more than 600,000 people in the U.S. live with kidney cancer.
